Home > conferences > conferences listings > conference details
Bookmark and Share email this event to a colleage
02 September 2010
life sciences/pharma sector

DNA Vaccines Forum 2008
Bridging the Gap between Technology and Application

Event Date: 10-11 Mar 2008
Location: The Millennium Gloucester Hotel, London, UK

key conference speakers

Dr. Philip Bergman
Chief Medical Officer, BrightHeart Veterinary Centers
Dr. Jedd Wolchok
Oncologist, Clinical Immunology Service, Memorial Sloane-Kettering Caner Center
Dr. Dennis Klinman
Head, Immune Modulation Group, Senior Investigator, National Institute of Health/National Cancer Institute, Formerly of the FDA
Dr. Jeffrey Ulmer
Head, Immunology and Cell Biology, Novartis
Dr. Peter Loudon
Head of Research, PowderMed, Subsidiary of Pfizer

key conference topics

  • Ascertaining How DNA Vaccines Work in the Immune System
  • Step by Step Approaches to Engineering DNA Vaccines
  • Analysing Innovative Delivery Methods
  • Clinical Strategies and Overcoming Trial Requirements
  • Recent Breakthroughs in Oncology, Infectious and Auto-Immune Diseases
  • key conference features

  • Understand the current status of DNA vaccines and examine developments behind the trials producing positive results
  • Investigate how DNA vaccines function in the immune system and innovative methods for improving immunogenicity
  • Learn step by step approaches for engineering DNA vaccines
  • Examine the data supporting licensed treatments in animals
  • conference focus

    Event Over view

    Fresh clinical data from those on the front lines of research and development shows compelling new evidence of the efficacy of DNA vaccines in animals and potentially humans. Propelled by new advancements in delivery methods and well-designed technology platforms, these case studies are fuelling new optimism and increased investment in the field.

    This marcus evans event brings together key academic and industry experts analysing innovative strategies for creating safe and effective DNA vaccines.

    conference sponsors
    Gold Sponsor


    Althea Technologies

    Exhibiton Sponsor


    Cyto Pulse Sciences

    Exhibition Sponsor


    Inovio

    Business Development Sponsor


    Ichor

    Business Development


    Retroscreen

    Business Development Sponsor


    Retroscreen Flucamp

    Media Partner


    who should attend the conference

    marcusevans invites Presidents, Directors and Heads of the following departments within Bio-pharmaceutical companies specifically focused in DNA vaccines:
    • Research and Development
    • Production
    • Research Scientists
    • Vaccine Research
    • Clinical Operations/ Development
    • Regulatory Affairs

    VPs, Directors and Heads from the following therapeutic departments within larger pharma organisations:
    • Oncology
    • Microbiology
    • Immunology
    • Molecular Biology
    • Infectious disease Programmes
    • Viral diseases
    • Functional Genomics
    • Gene Therapy

    the conference venue

    The Millennium Gloucester Hotel London Kensington
    4 - 18 Harrington Gardens
    London SW7 4LH, The United Kingdom
    +44 (0) 20 7373 6030
    www.millenniumhotels.com

    the conference organisers

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.



    conference speakers

    Peggy Teng
    Associate Director, Genomics
    Althea Technologies

    Dr. Hideki Garren
    Co-Founder and Vice President, Research
    Bayhill Therapeutics

    Dr. Philip Bergman
    Chief Medical Officer
    BrightHeart Veterinary Centers

    Dr. Alan D. King
    Chief Science Officer
    Cyto Pulse Sciences

    Dr. Mike Gill
    Senior Director of Biological Research and Development
    Fort Dodge Animal Health, Division of Wyeth

    Prof. Dr. Ralf Wagner
    Chief Executive Officer and Chief Science Officer
    Geneart

    Dr. Drew Hanaman
    Vice President, Research and Development
    Ichor Medical Systems

    Dr. Britta E Wahren
    Professor of Virology
    Karolinska Institute

    Dr. Jedd Wolchok
    Oncologist, Clinical Immunology Service
    Memorial Sloane-Kettering Caner Center

    Dr. Nicola La Monica
    Lead Scientist
    Merck & Co, Instituto di Recerche di Biologia Molecolare

    Dr. Robert Nordgren
    Head of Biologics Research and Development
    Merial

    Dr. Dennis Klinman
    Head, Immune Modulation Group, Senior Investigator
    National Institute of Health/National Cancer Institute, Formerly of the FDA

    Dr. Jeffrey Ulmer
    Head, Immunology and Cell Biology
    Novartis

    Dr. Bettina Klug
    Advanced Therapy Medicinal Products, Tissue Preparation
    Paul Ehrlich Institute

    Dr. Martin Schleef
    Founder
    Plasmid Factory

    Dr. Peter Loudon
    Head of Research
    PowderMed, Subsidiary of Pfizer

    Dr. Joerg Schenider
    Department Head, Molecular Immunology
    Transgene

    Dr. Richard Heller
    Experimental Therapeutics Cutaneous Oncology
    H Lee Moffit Cancer Center and Research Institute/ University of South Florida

    Dr. Freda Stevenson
    Professor of Immunology, Tenovus Laboratory
    University of Southampton

    Dr. De-chu Tang
    Founder, Vice President and Chief Technical Officer
    Vaxin

    general enquiries

    Ola Samuelsson

    11 Connaught Place
    London
    W2 2ET

    Telephone:
    +44(0)20 3002 3276
    Fax: +44(0)20 3002 3016
    Email: olas@marcusevansuk.com


    sponsorship opportunities

    Nisha Vyas

    11 Connaught Place
    LONDON
    W2 2ET

    Telephone: +44(0)20 3002 3171
    Fax: +44 (0)20 3002 3484
    Email: nishav@marcusevansuk.com

    conference quote

    "Delivering the Goods, DNA Vaccines Now on the Rise"

    This high-level event focuses on validating technology platforms that optimise clinical results as well as evaluating the performance of innovative new delivery devices and their technical applications critical to achieving success.